The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly

Molecular Cell

Volumn 11, Issue 3, 2003, Pages 605-617

  Greenwald, Jason ^a   Groppe, Jay ^a   Gray, Peter ^a   Wiater, Ezra ^a   Kwiatkowski, Witek ^a   Vale, Wylie ^a   Choe, Senyon ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR; LIGAND; OSTEOGENIC PROTEIN 1; RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CRYSTAL STRUCTURE; CYTOPLASM; FEMALE; HUMAN; HUMAN CELL; MOLECULAR MODEL; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN STRUCTURE; RECEPTOR AFFINITY;

ANIMALIA;

EID: 0037351880     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00094-7     Document Type: Article

References (64)

1. Attisano L., Wrana J.L., Cheifetz S., Massagué J. Novel activin receptors. distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors Cell. 68:1992;97-108.
2. Attisano L., Wrana J.L., Montalvo E., Massagué J. Activation of signalling by the activin receptor complex. Mol. Cell. Biol. 16:1996;1066-1073.
3. Barton G.J. Alscript. a tool to format multiple sequence alignments Protein Eng. 6:1993;37-40.
4. Brummel T., Abdollah S., Haerry T.E., Shimell M.J., Merriam J., Raftery L., Wrana J.L., O'Connor M.B. The Drosophila activin receptor baboon signals through dSmad2 and controls cell proliferation but not patterning during larval development. Genes Dev. 13:1999;98-111.
5. Cárcamo J., Weis F.M., Ventura F., Wieser R., Wrana J.L., Attisano L., Massagué J. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin. Mol. Cell. Biol. 14:1994;3810-3821.
6. CCP4 Collaborative Computational Project 4) The CCP suite. programs for protein crystallography Acta Crystallogr. D. 50:1994;760-776.
7. Chen R.H., Derynck R. Homomeric interactions between type II transforming growth factor-β receptors. J. Biol. Chem. 269:1994;22868-22874.
8. Childs S.R., Wrana J.L., Arora K., Attisano L., O'Connor M.B., Massagué J. Identification of a Drosophila activin receptor. Proc. Natl. Acad. Sci. USA. 90:1993;9475-9479.
9. Clackson T., Wells J.A. A hot spot of binding energy in a hormone-receptor interface. Science. 267:1995;383-386.
10. Clarke T.R., Hoshiya Y., Yi S.E., Liu X., Lyons K.M., Donahoe P.K. Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression. Mol. Endocrinol. 15:2001;946-959.
11. De Crescenzo G., Grothe S., Zwaagstra J., Tsang M., O'Connor-McCourt M.D. Real-time monitoring of the interactions of transforming growth factor-β (TGF-β) isoforms with latency-associated protein and the ectodomains of the TGF-β type II and III receptors reveals different kinetic models and stoichiometries of binding. J. Biol. Chem. 276:2001;29632-29643.
12. de Vos A.M., Ultsch M., Kossiakoff A.A. Human growth hormone and extracellular domain of its receptor. crystal structure of the complex Science. 255:1992;306-312.
13. Dudley A.T., Lyons K.M., Robertson E.J. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. 9:1995;2795-2807.
14. Eldar A., Dorfman R., Weiss D., Ashe H., Shilo B.Z., Barkai N. Robustness of the BMP morphogen gradient in Drosophila embryonic patterning. Nature. 419:2002;304-308.
15. Garrett T.P., McKern N.M., Lou M., Elleman T.C., Adams T.E., Lovrecz G.O., Zhu H.J., Walker F., Frenkel M.J., Hoyne P.A.et al. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor α Cell. 110:2002;763-773.
16. Gilboa L., Wells R.G., Lodish H.F., Henis Y.I. Oligomeric structure of type I and type II transforming growth factor β receptors. homodimers form in the ER and persist at the plasma membrane J. Cell Biol. 140:1998;767-777.
17. Gilboa L., Nohe A., Geissendorfer T., Sebald W., Henis Y.I., Knaus P. Bone morphogenetic protein receptor complexes on the surface of live cells. a new oligomerization mode for serine/threonine kinase receptors Mol. Biol. Cell. 11:2000;1023-1035.
18. Gray P.C., Greenwald J., Blount A.L., Kunitake K.S., Donaldson C.J., Choe S., Vale W. Identification of a binding site on the type II activin receptor for activin and inhibin. J. Biol. Chem. 275:2000;3206-3212.
19. Greenwald J., Le V., Corrigan A., Fischer W., Komives E., Vale W., Choe S. Characterization of the extracellular ligand-binding domain of the type II activin receptor. Biochemistry. 37:1998;16711-16718.
20. Greenwald J., Fischer W.H., Vale W.W., Choe S. Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase. Nat. Struct. Biol. 6:1999;18-22.
21. Griffith D.L., Keck P.C., Sampath T.K., Rueger D.C., Carlson W.D. Three-dimensional structure of recombinant human osteogenic protein 1. structural paradigm for the transforming growth factor β superfamily Proc. Natl. Acad. Sci. USA. 93:1996;878-883.
22. Hart P.J., Deep S., Taylor A.B., Shu Z., Hinck C.S., Hinck A.P. Crystal structure of the human TβR2 ectodomain-TGF-β3 complex. Nat. Struct. Biol. 9:2002;203-208.
23. Hata A., Seoane J., Lagna G., Montalvo E., Hemmati-Brivanlou A., Massagué J. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell. 100:2000;229-240.
24. Hatta T., Konishi H., Katoh E., Natsume T., Ueno N., Kobayashi Y., Yamazaki T. Identification of the ligand-binding site of the BMP type IA receptor for BMP-4. Biopolymers. 55:2000;399-406.
25. Hogan B.L. Bone morphogenetic proteins. multifunctional regulators of vertebrate development Genes Dev. 10:1996;1580-1594.
26. Hunter T. Signaling - 2000 and beyond. Cell. 100:2000;113-127.
27. Huse M., Chen Y.G., Massagué J., Kuriyan J. Crystal structure of the cytoplasmic domain of the type I TGF β receptor in complex with FKBP12. Cell. 96:1999;425-436.
28. Jones T.A., Zou J.Y., Cowan S.W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:1991;100-119.
29. Kingsley D.M. The TGF-β superfamily. new members, new receptors, and new genetic tests of function in different organisms Genes Dev. 8:1994;133-146.
30. Kirsch T., Sebald W., Dreyer M.K. Crystal structure of the BMP-2-BRIA ectodomain complex. Nat. Struct. Biol. 7:2000;492-496. a.
31. Kirsch T., Nickel J., Sebald W. BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II. EMBO J. 19:2000;3314-3324. b.
32. Kirsch T., Nickel J., Sebald W. Isolation of recombinant BMP receptor IA ectodomain and its 2:1 complex with BMP-2. FEBS Lett. 468:2000;215-219. c.
33. Knaus P., Sebald W. Cooperativity of binding epitopes and receptor chains in the BMP/TGFβ superfamily. Biol. Chem. 382:2001;1189-1195.
34. Koenig B.B., Cook J.S., Wolsing D.H., Ting J., Tiesman J.P., Correa P.E., Olson C.A., Pecquet A.L., Ventura F., Grant R.A.et al. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol. Cell. Biol. 14:1994;5961-5974.
35. Kraulis P.J. Molscript. a program to produce both detailed and schematic plots of protein structures J. Appl. Crystallogr. 24:1991;946-950.
36. Kutty G., Kutty R.K., Samuel W., Duncan T., Jaworski C., Wiggert B. Identification of a new member of transforming growth factor-beta superfamily in Drosophila. the first invertebrate activin gene Biochem. Biophys. Res. Commun. 246:1998;644-649.
37. Lebrun J.J., Vale W.W. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation. Mol. Cell. Biol. 17:1997;1682-1691.
38. Letsou A., Arora K., Wrana J.L., Simin K., Twombly V., Jamal J., Staehling-Hampton K., Hoffmann F.M., Gelbart W.M., Massagué J.et al. Drosophila Dpp signaling is mediated by the punt gene product. a dual ligand-binding type II receptor of the TGF β receptor family Cell. 80:1995;899-908.
39. Lim D.A., Tramontin A.D., Trevejo J.M., Herrera D.G., Garcia-Verdugo J.M., Alvarez-Buylla A. Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron. 28:2000;713-726.
40. Luo G., Hofmann C., Bronckers A.L., Sohocki M., Bradley A., Karsenty G. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev. 9:1995;2808-2820.
41. Macias-Silva M., Hoodless P.A., Tang S.J., Buchwald M., Wrana J.L. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J. Biol. Chem. 273:1998;25628-25636.
42. Massagué J. TGF-beta signal transduction. Annu. Rev. Biochem. 67:1998;753-791.
43. Massagué J., Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 19:2000;1745-1754.
44. McDonald N.Q., Hendrickson W.A. A structural superfamily of growth factors containing a cystine knot motif. Cell. 73:1993;421-424.
45. Ogiso H., Ishitani R., Nureki O., Fukai S., Yamanaka M., Kim J.H., Saito K., Sakamoto A., Inoue M., Shirouzu M., Yokoyama S. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell. 110:2002;775-787.
46. Otwinowski Z. Data collection and processing. Sawyer L., Isaacs N., Burley S. Proceedings of the CCP4 Study Weekend. 1993;Daresbury Laboratory, Warrington, UK. 56-62.pp.
47. Pecina M., Giltaij L.R., Vukicevic S. Orthopaedic applications of osteogenic protein-1 (BMP-7). Int. Orthop. 25:2001;203-208.
48. Pellegrini L., Burke D.F., von Delft F., Mulloy B., Blundell T.L. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature. 407:2000;1029-1034.
49. Penton A., Chen Y., Staehling-Hampton K., Wrana J.L., Attisano L., Szidonya J., Cassill J.A., Massagué J., Hoffmann F.M. Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor. Cell. 78:1994;239-250.
50. Philippsen A. DINO. Visualizing Structural Biology http://www.dino3d.org:2001.
51. Qian S.W., Burmester J.K., Tsang M.L., Weatherbee J.A., Hinck A.P., Ohlsen D.J., Sporn M.B., Roberts A.B. Binding affinity of transforming growth factor-β for its type II receptor is determined by the C-terminal region of the molecule. J. Biol. Chem. 271:1996;30656-30662.
52. Russell R.B., Barton G.J. Multiple protein sequence alignment from tertiary structure comparison. assignment of global and residue confidence levels Proteins. 14:1992;309-323.
53. Sampath T.K., Maliakal J.C., Hauschka P.V., Jones W.K., Sasak H., Tucker R.F., White K.H., Coughlin J.E., Tucker M.M., Pang R.H.et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem. 267:1992;20352-20362.
54. Syed R.S., Reid S.W., Li C., Cheetham J.C., Aoki K.H., Liu B., Zhan H., Osslund T.D., Chirino A.J., Zhang J.et al. Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature. 395:1998;511-516.
55. Thompson J.D., Higgins D.G., Gibson T.J. Clustal w. improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice Nucleic Acids Res. 22:1994;4673-4680.
56. Tsuchida K., Vaughan J.M., Wiater E., Gaddy-Kurten D., Vale W.W. Inactivation of activin-dependent transcription by kinase-deficient activin receptors. Endocrinology. 136:1995;5493-5503.
57. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:1990;203-212.
58. Visser J.A., Olaso R., Verhoef-Post M., Kramer P., Themmen A.P., Ingraham H.A. The serine/threonine transmembrane receptor ALK2 mediates Mullerian inhibiting substance signaling. Mol. Endocrinol. 15:2001;936-945.
59. Weis-Garcia F., Massagué J. Complementation between kinase-defective and activation-defective TGF-beta receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J. 15:1996;276-289.
60. Wrana J.L., Attisano L., Wieser R., Ventura F., Massagué J. Mechanism of activation of the TGF-β receptor. Nature. 370:1994;341-347.
61. Wuytens G., Verschueren K., de Winter J.P., Gajendran N., Beek L., Devos K., Bosman F., de Waele P., Andries M., van den Eijnden-van Raaij A.J.et al. Identification of two amino acids in activin A that are important for biological activity and binding to the activin type II receptors. J. Biol. Chem. 274:1999;9821-9827.
62. Yamashita H., ten Dijke P., Huylebroeck D., Sampath T.K., Andries M., Smith J.C., Heldin C.H., Miyazono K. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J. Cell Biol. 130:1995;217-226.
63. Zhu H.J., Sizeland A.M. Extracellular domain of the transforming growth factor-beta receptor negatively regulates ligand-independent receptor activation. J. Biol. Chem. 274:1999;29220-29227.
64. Zimmerman L.B., De Jesus-Escobar J.M., Harland R.M. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell. 86:1996;599-606.